Company profile ELYM
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Eliem Therapeutics expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 36 | 176 388.9% QoQ | 124 -29.5% QoQ | 70 -43.5% QoQ |
| 2020 | 43 19.4% YoY -38.6% QoQ | 154 -12.5% YoY 258.1% QoQ | 234 88.7% YoY 51.9% QoQ | 119 70.0% YoY -49.1% QoQ |
| 2021 | 185 330.2% YoY 55.5% QoQ | 125 -18.8% YoY -32.4% QoQ | 489 109.0% YoY 291.2% QoQ | 191 60.5% YoY -60.9% QoQ |
| 2022 | 187 1.1% YoY -2.1% QoQ | 154 23.2% YoY -17.6% QoQ | 245 -49.9% YoY 59.1% QoQ | 40 -79.1% YoY -83.7% QoQ |
| 2023 | 141 -24.6% YoY 252.5% QoQ | 48 -68.8% YoY -66.0% QoQ | 168 -31.4% YoY 250.0% QoQ | 165 312.5% YoY -1.8% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Eliem Therapeutics was 11.85 per week. The last year interest of Eliem Therapeutics compared to the last 5 years has changed by -20.34%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 9.39%.
There is not enough data for Eliem Therapeutics stock price to provide analysis
There is not enough data for Eliem Therapeutics stock price to provide correlation calculation
There is not enough data for Eliem Therapeutics stock price to provide analysis
There is not enough data for ETX-123 clinical trial to provide analysis
There is not enough data for ETX-123 clinical trial to provide correlation calculation
There is not enough data for ETX-123 clinical trial to provide analysis
There is not enough data for ETX-155 major depressive disorder to provide analysis
There is not enough data for ETX-155 major depressive disorder to provide correlation calculation
There is not enough data for ETX-155 major depressive disorder to provide analysis
There is not enough data for Kv7.2/3 potassium channel opener to provide analysis
There is not enough data for Kv7.2/3 potassium channel opener to provide correlation calculation
There is not enough data for Kv7.2/3 potassium channel opener to provide analysis
There is not enough data for Neuronal excitability disorders to provide analysis
There is not enough data for Neuronal excitability disorders to provide correlation calculation
There is not enough data for Neuronal excitability disorders to provide analysis
After 39 days of this quarter the interest is at 120.0. Based on that we can calculate that during remaining 52 days it will total up to 280.0. Chronic pain treatments expected interest is significantly lower compared to previous quarter (-49.1%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 241 | 165 -31.5% QoQ | 355 115.2% QoQ | 138 -61.1% QoQ |
| 2020 | 227 -5.8% YoY 64.5% QoQ | 219 32.7% YoY -3.5% QoQ | 207 -41.7% YoY -5.5% QoQ | 356 158.0% YoY 72.0% QoQ |
| 2021 | 278 22.5% YoY -21.9% QoQ | 295 34.7% YoY 6.1% QoQ | 320 54.6% YoY 8.5% QoQ | 367 3.1% YoY 14.7% QoQ |
| 2022 | 336 20.9% YoY -8.4% QoQ | 314 6.4% YoY -6.5% QoQ | 441 37.8% YoY 40.4% QoQ | 263 -28.3% YoY -40.4% QoQ |
| 2023 | 434 29.2% YoY 65.0% QoQ | 258 -17.8% YoY -40.6% QoQ | 331 -24.9% YoY 28.3% QoQ | 550 109.1% YoY 66.2% QoQ |
| 2024 | 120 -72.4% YoY -78.2% QoQ | - | - | - |
The average 5 years interest of Chronic pain treatments was 23.81 per week. The last year interest of Chronic pain treatments compared to the last 5 years has changed by 19.19%. The interest for Chronic pain treatments is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 52.74%.
There is not enough data for Psychiatry therapies to provide analysis
There is not enough data for Psychiatry therapies to provide correlation calculation
There is not enough data for Psychiatry therapies to provide analysis
After 39 days of this quarter the interest is at 82.0. Based on that we can calculate that during remaining 52 days it will total up to 191.0. Epilepsy treatments expected interest is significantly lower compared to previous quarter (-46.5%) and same quarter last year (-66.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 363 | 241 -33.6% QoQ | 194 -19.5% QoQ | 430 121.6% QoQ |
| 2020 | 281 -22.6% YoY -34.7% QoQ | 261 8.3% YoY -7.1% QoQ | 266 37.1% YoY 1.9% QoQ | 277 -35.6% YoY 4.1% QoQ |
| 2021 | 352 25.3% YoY 27.1% QoQ | 191 -26.8% YoY -45.7% QoQ | 131 -50.8% YoY -31.4% QoQ | 245 -11.6% YoY 87.0% QoQ |
| 2022 | 264 -25.0% YoY 7.8% QoQ | 451 136.1% YoY 70.8% QoQ | 268 104.6% YoY -40.6% QoQ | 323 31.8% YoY 20.5% QoQ |
| 2023 | 568 115.2% YoY 75.9% QoQ | 352 -22.0% YoY -38.0% QoQ | 132 -50.7% YoY -62.5% QoQ | 357 10.5% YoY 170.5% QoQ |
| 2024 | 82 -85.6% YoY -77.0% QoQ | - | - | - |
The average 5 years interest of Epilepsy treatments was 23.1 per week. The last year interest of Epilepsy treatments compared to the last 5 years has changed by 0.82%. The interest for Epilepsy treatments is seasonal. The last year interest is comparable to 5 years ago. It has changed only by -9.41%.
There is not enough data for Eliem Therapeutics careers to provide analysis
There is not enough data for Eliem Therapeutics careers to provide correlation calculation
There is not enough data for Eliem Therapeutics careers to provide analysis